Showing results (121-130 of 136) with videos related to
Sort By:
Pageof 14
Brazilian Journal of Biology = Revista Brasleira De Biologia|April 7, 2021
Cutaneous leishmaniasis-Awareness, knowledge and practices among general population in rural and urban areas in Malakand region, PakistanW Khan, I Khan, H Ullah, et al.Brazilian Journal of Biology = Revista Brasleira De Biologia|March 31, 2021
Cutaneous leishmaniasis-Awareness, knowledge and practices among general population in rural and urban areas in Malakand region, PakistanW Khan, I Khan, H Ullah, et al.Journal of Thrombosis and Haemostasis : JTH|August 30, 2008
Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2P C J Armstrong, N J Truss, F Y Ali, et al.Molecular Pharmaceutics|May 1, 2020
Antibiotic-in-Cyclodextrin-in-Liposomes: Formulation Development and Interactions with Model Bacterial MembranesKalliopi-Kelli A Vandera, Pietro Picconi, Margarita Valero, et al.The Lancet. Haematology|October 10, 2021
Intralesional TTI-621, a novel biologic targeting the innate immune checkpoint CD47, in patients with relapsed or refractory mycosis fungoides or Sézary syndrome: a multicentre, phase 1 studyChristiane Querfeld, John A Thompson, Matthew H Taylor, et al.Blood|March 8, 2012
Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphomaSteven M Horwitz, Youn H Kim, Francine Foss, et al.British Journal of Haematology|May 22, 2023
Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphomaRobert Stuver, Steven M Horwitz, Ranjana H Advani, et al.The Lancet. Haematology|May 28, 2021
Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion studyMehdi Hamadani, Graham P Collins, Paolo F Caimi, et al.Journal of Medical Microbiology|October 1, 2021
2-Alkyl-4-quinolone quorum sensing molecules are biomarkers for culture-independent <i>Pseudomonas aeruginosa</i> burden in adults with cystic fibrosisNur Masirah M Zain, Karmel Webb, Iain Stewart, et al.Journal of Cachexia, Sarcopenia and Muscle|March 27, 2020
Abnormal body composition is a predictor of adverse outcomes after autologous haematopoietic cell transplantationSaro H Armenian, Aleksi Iukuridze, Jennifer Berano Teh, et al.Pageof 14